_1589787895398.png?format=webp&height=120&width=120){kind=logo}
About Narya
Narya is a venture capital firm founded in 2020. It is primarily based out of Cincinnati, United States. As of Jun 2026, Narya is an active investor, having invested in 15 companies, with 4 new investments in the last 12 months. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and High Tech. Most recently it participated in the $***** Series D round of Beren Therapeutics Overall, Narya portfolio has seen 3 unicorns, 3 IPOs and 1 acquisition including key companies like Chapter, AcreTrader and Rumble. A lot of funds co-invest with Narya, with names like Peter Thiel sharing a substantial percentage of its portfolio. Narya has team of 3 people including 3 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 4 more
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
Narya's List of Top Investments
Narya has a portfolio of 15 companies, including 3 unicorns. Their most notable investments are in Kriya Therapeutics and Chapter.Their portfolio spans across United States, Canada and Germany. They have invested in Life Sciences, Enterprise Applications, High Tech and 10 other sectors, across stages such as Series A, Seed and 4 more. Here is the list of top investments by Narya:
1. Chapter
Digital medicare plan and benefits management tool for employees and individuals. The company has developed a platform that enables users to compare and calculate different insurance plans. It has features for personalizing plans and financial saving calculators as well.
Key facts about Chapter
- Founded Year: 2013
- Location: New York City (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $284M
- Employee Count: 254 as on Jun 30, 2026
- Investors: Generation Investment Management, Maverick Ventures and 11 Others
- Latest Funding Round: Series E, Apr 09, 2026, $*****
- Highlight: Editors' Pick
2. AcreTrader
Online platform focused on farmland investments. It enables users to diversify cash flow by renting land to farmers. It helps in farm management, paperwork, and payments. Users can invest in multiple options as alternative assets for holding farmlands. Also, features news updates as a reference for investors.
Key facts about AcreTrader
- Founded Year: 2018
- Location: Fayetteville (United States)
- Stage: Acquired
- Total Funding till date: $128M
- Employee Count: 132 as on Dec 31, 2022
- Investors: Revolution, Jump Capital and 5 Others
- Latest Funding Round: Series C, Jul 06, 2026, $*****
- Highlight: Acquired
3. Rumble
Video creator monetization platform. The platform allows video creators to host, share, create channels, monetize, and distribute their content across the internet and television from a single centralized video platform. Through the platform video player, both the video creator and publisher are able to generate revenue from embedding the player on their own blogs, websites, and social channels.
Key facts about Rumble
- Founded Year: 2013
- Location: Toronto (Canada)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Stage: Public
- Employee Count: 278 as on May 31, 2026
- Investors: Colt Ventures, Valor Equity Partners and 4 Others
- Latest Funding Round: Post IPO, Dec 23, 2024, $*****
- Highlight: Public
Developer of therapeutic solutions for the treatment of diabetes. The company has developed AAV-based gene therapies for the treatment of type 1 and type 2 diabetes. Its drug candidate KT-A112 contains insulin and glucokinase proteins that help in treating Type 1 & Type 2 diabetes mellitus. It also provides KT-A522 with glucagon-like peptide (GLP-1) receptor agonist for the treatment of Type 2 diabetes, KT-A832 insulin growth factor that helps in treating diabetes mellitus.
Key facts about Kriya Therapeutics
- Founded Year: 2012
- Location: Redwood City (United States)
- Stage: Series D
- Total Funding till date: $938M
- Employee Count: 10 - 49 as on Mar 01, 2026
- Investors: Foresite Capital, CAM Capital and 16 Others
- Latest Funding Round: Series D, Jul 31, 2025, $*****
- Highlight: Editors' Pick
5. Branch
Provider of auto and home insurance solutions. It offers claims and offers insurance, home insurance, auto insurance, bundled insurance, and remote jobs. It also offers a way to file a claim and switch insurance companies. It simplifies the insurance buying experience with instant pricing and coverage options.
Key facts about Branch
Narya's Year-on-Year Investment Trends
Narya has invested in 15 companies over the last 6 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 5 investments, while as of Jun 2026, it has made 5 investments in this year. Its most recent first time investment was in Beren Therapeutics and most recent follow-on round was in True Anomaly.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 3 | 2 | 5 |
2025 | 1 | 4 | 5 |
2024 | 2 | 1 | 3 |
2023 | 1 | 1 | 2 |
2022 | 2 | 3 | 5 |
2021 | 4 | 1 | 5 |
2020 | 2 | 0 | 2 |
Narya's Investments by Stage
Narya has made 5 investments in Series A stage with an average round size of $37.5M, 3 investments in Seed stage with an average round size of $9.43M and 3 investments in Series B stage with an average round size of $49.3M.Stage of entry | No. of Investments |
|---|---|
Series A | 5 |
Seed | 3 |
Series B | 3 |
Post IPO | 2 |
Series C | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Narya's Investments by Sector
Narya has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, FinTech, Consumer and Financial Services. Notably, it has invested in 12 Tech companies, 9 Enterprise (B2B) companies, 4 Consumer (B2C) companies and at least 4 companies focusing on Software.Sector | No. of Investments |
|---|---|
Life Sciences | 4 |
Enterprise Applications | 3 |
FinTech | 3 |
Consumer | 2 |
Financial Services | 2 |
Others | 14 |
Note: We have considered here, only first round of investments
Narya's Investments by Geography
Narya has made most investments in United States (13), followed by Canada where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 13 |
Canada | 1 |
Germany | 1 |
Note: We have considered here, only first round of investments
Narya's recent investments
Narya has made 5 investments in 2026 so far. Beren Therapeutics and True Anomaly are the latest among them.Here are the most recent investments by Narya:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 10, 2026 | Germany | Series D | 6263 | ||
Apr 28, 2026 | United States | Series D | 9368 | [+12] | |
Apr 09, 2026 | United States | Series E | 1608 | ||
Mar 16, 2026 | United States | Seed | 9815 | [+1] | |
Jan 08, 2026 | United States | Series A | 1173 |
Unicorns in Narya's Portfolio
Narya has 3 unicorns in its portfolio - True Anomaly, Chapter and Branch. The most recent unicorn in their portfolio is True Anomaly. It became a unicorn in 2026, 3 years after Narya first invested in it.Here is a list of unicorns in Narya's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
60 | Developer of materials and products for space solutions | 2022 | Centennial | Series D | tgfqxto | ||
73 | Digital medicare plan and benefits management tool for employees and individuals | 2013 | New York City | Series E | lmcbqkd | ||
63 | Provider of auto and home insurance solutions | 2017 | Columbus | Series D | dml{eow |
IPOs and Publicly Listed companies in Narya's Portfolio
3 of Narya's portfolio companies have become public. Strive got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Nov 2025 at marketcap of $160M and Rumble got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ).Here are Narya's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 10, 2025 | Jul 23, 2024 | Series B | 4873 | |
Sep 16, 2022 | May 20, 2021 | Post IPO | 1333 | |
Jun 19, 2020 | Aug 06, 2020 | Post IPO | 4941 |
Acquired companies in Narya's Portfolio
1 company from Narya's portfolio has been acquired. The most recent acquisition was AcreTrader in Aug 2025 by Proterra Investment Partners for $*****.Here are Narya's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 12, 2025 | Mar 01, 2021 | Series A | 6114 |
Team profile of Narya
Narya has a team of 3 members including 3 Partners located in United States. Narya's team does not sit on the board of any company as of now.Here is a list of all team members in Narya:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Cincinnati | - | - | |
Partner | Darien | - | ||
Partner | United States | - |
Co-investors of Narya
Over the past 6 years, 127 investors have co-invested in Narya's portfolio companies. This includes funds and angels.
- Invested before Narya: Revolution, Techstars and 28 others have invested in rounds before Narya. There are 2 companies where Revolution has invested before Narya and 1 company where Techstars has invested before Narya.
- Top Co-investors of Narya: 57 investors entered a company along with Narya. These include investors like Peter Thiel (3 companies).
- Invested after Narya: A total of 40 investors have invested in Narya's portfolio after their investments. Top Investors include Addition (1 company), Stripes (1 company) and Generation Investment Management (1 company).
Recent News related to Narya
•
Beren Therapeutics Announces Six Presentations at the 2026 Ara Parseghian Medical Research Fund (APMRF) ConferenceBusiness Wire•May 29, 2026•Beren Therapeutics, JIC Venture Growth Investments, Narya, Eisai and 2 others
•
Reprogram Biosciences Closes $6M Seed FinancingMassinvestor•May 27, 2026•Reprogram Biosciences, Narya, 1517 Fund, Unshackled Ventures
•
True Anomaly Closes $650M Series D Funding RoundPayload•Apr 28, 2026•Eclipse, True Anomaly, Riot, Accel and 13 others
•
Chapter Secures $100M to Bridge Seniors and AI TechVentureburn•Apr 09, 2026•Chapter, Fifth Down Capital, Generation Investment Management, 8VC and 9 others
•
Valinor Enterprises Scores $54M Series AMassinvestor•Jan 08, 2026•Friends & Family Capital, Fifth Down Capital, Red Cell Partners, XYZ Venture Capital and 4 others
•
Peter Thiel-backed Peptilogics raises $78M for prosthetic joint infection programEndpoints•Oct 16, 2025•Peptilogics, Presight Capital, Founders Fund, Beyond Venture Partners and 5 others
•
AP Kriya Announces $320 Million Series D Financing to Advance Pipeline of Gene TherapiesBakersfield•Sep 10, 2025•Premji Invest, Patient Square Capital, Kriya Therapeutics, Narya and 1 other
•
Chapter Raises $75 Million Led by Stripes to Build the Future of Medicare and Retirement GuidanceBusiness Wire•Apr 16, 2025•Stripes, Chapter, XYZ Venture Capital, Susa Ventures and 3 others
•
Morris Industries Invests in Series B Round of Strive EnterprisesBusiness Wire•Jul 26, 2024•Morris Industries, Cantor Fitzgerald, Narya
•
Strive Raises $30 Million In Series B Funding RoundPR Newswire•Jul 23, 2024•Strive Enterprises, Cantor Fitzgerald, Narya, Strive and 2 others
